Researchers are studying high dose vitamin C as part of treatment for several cancers, including pancreatic cancer. These high doses of vitamin C (pharmacologic ascorbate) are not taken orally (by mouth), but in IVs (taken intravenously). It is always given alongside chemotherapy.
The intravenous vitamin C doses are 150 to 190 times larger than ordinary vitamin C tablets that are taken orally. This is because orally taken vitamin C cannot reach the blood levels needed to produce a pharmacologic effect.
Some of the results are amazing. For example, persons with pancreatic cancer it doubled survival compared to chemotherapy alone (from 8 months to 16 months) , and those receiving vitamin C used alongside standard chemotherapy had fewer side effects than when using chemotherapy alone. It is still unclear for which cancers the vitamin C treatment works and for which it doesn't.
The only problem is that pharma companies may not be interested because it can not be patented, and can't be developed as a new drug that they can make big profits off of. It's plain old vitamin C - but not as a nutritional supplement, but used as a medical drug (pharmacologic ascorbate).
Click on the link for the full story and dosing details. Excerpts from Medscape: Vitamin C’s Potential Use in Cancer Is Getting a Second Look
When Garry Buettner, PhD, who has been studying the chemistry and biochemistry of vitamin C for at least four decades, was diagnosed with myelodysplastic syndromes (MDS), he applied his research to his own life — reviewing the data and designing a protocol for his treatment. ...continue reading "High Dose Vitamin C As Part of Cancer Treatment?"
There may be new treatments on the horizon for the most aggressive and deadly brain cancer known as glioblastoma. The median survival is less than one year, so this is very exciting news.